Dr. Di Stasi's interest is to provide clinical care to patients with hematological malignancies, myelodysplastic syndromes, acute leukemias and lymphomas while being directly involved in laboratory research as well. His passion is to dedicate his practice to the discovery of novel immunotherapy strategies for disease eradication and conditioning to a hematopoietic stem cell transplantation, as well as strategies to control the toxicities of those novel forms of treatment. His specific research interests include: T-cell Immunotherapy for leukemias and lymphomas Hematopoietic stem cell transplantation Suicide gene strategies for the safety of cellular therapies

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Bristol Myers Squibb
Jazz Pharmaceuticals
AbbVie
Genentech
Amgen

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

https://www.guidestar.org/profile/45-5354811